Solventum

Solventum is a healthcare innovation company founded in 2024 as an independent business following its spin-off from 3M. It works at the intersection of health, material and data science to develop solutions intended to improve patient outcomes across the continuum of care. The company reports annual sales of approximately $8.3 billion and employs more than 10,000 people worldwide, drawing on a legacy of healthcare solutions spanning more than 70 years.

Its portfolio spans eight areas: advanced wound care, surgical solutions, IV site management, sterilization assurance, patient monitoring technologies, dental and orthodontic solutions, health information systems built on clinical intelligence and data science, and purification and filtration technologies serving biopharmaceutical, manufacturing and water applications. The breadth of these operations places the company across several industries, among them healthcare, medical devices, dental and orthodontics, health IT, biopharmaceuticals, manufacturing and water treatment.

Technical work at Solventum draws on health science, material science, data science, clinical intelligence, medical device technology, purification and filtration technology and health information systems. The company operates worldwide and describes its approach as patient-centred, with a focus on deep scientific expertise and on innovation that addresses the challenges healthcare professionals face. Its stated aim is to enable better, smarter and safer healthcare.